McKesson recalls

Recall found. McKesson is named in FDA Class II recall D-0714-2026 covering Gemcitabine Injection. Hazard: Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment. Identifying details: Lot #: CB0046, Exp. Date 06/2027. Status: Ongoing.

Models with recalls

Gemcitabine Injection (1)

All McKesson recalls

FDA Class II · Drug · July 8, 2026

Gemcitabine Injection recall — McKesson

Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.

Official ID D-0714-2026 · Official record ↗

Verify with the official sources:

CPSC — consumer products ↗ (aggregated here)
NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
FDA — food, drugs, medical devices ↗ (aggregated here)
USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
Recalls.gov — the U.S. government’s all-agency portal ↗

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked September 7, 2026 at 6:00 AM UTC.